ICM
California
About ICM
ICM develops a gene theraphy aimed to combat osteoarthritis and age-related mascular disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 501 – 1,000
- Total funding: $1.8M
- Funding stage: Early Stage Venture
- Last round: Series B (Jun 2017)
Industries & Categories
Biotechnology, Health Care
Canonical: https://fsome.com/organization/icm-156464 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.